Newswise — NASHVILLE, Tenn., Feb. 7, 2022 /PRNewswire/ — OneOncology, the national platform for independent community oncology practices, today announced that Davey Daniel, MD, has been named Chief Medical Officer, succeeding Lee Schwartzberg , MD. Schwartzberg was a founding member of the platform’s clinical office and will remain a senior advisor to the company.
Daniel, a graduate of Johns Hopkins School of Medicine, did his fellowship at Duke University Medical Center.
Dr. Daniel is currently Vice Chair of OneCouncil, the platform’s all-physician advisory board for clinical and strategic initiatives. He leads medical education initiatives, including virtual tumor counseling, a physician conference that OneOncology will hold in fall 2022, and other learning opportunities for physicians and fellows. Daniel was also instrumental in the launch of OneCommunity, a digital oncology platform used to review medical cases in the practices of the partnership.
A lung cancer specialist who will continue to treat patients at Tennessee Oncology in Chattanooga, Dr. Daniel received his medical degree from Johns Hopkins School of Medicine and completed his fellowship at Duke University Medical Center. While at Duke, Daniel met his future wife Brooke Daniel, a breast cancer oncologist who also practices at Tennessee Oncology in Chattanooga.
“Dr. Daniel is a servant leader in the truest sense of the word,” said Jeff Patton, MD, CEO of OneOncology. “Having trained at some of the nation’s most prestigious academic institutions, his passion for advancing science, delivering the highest quality patient-centered care, and commitment to improving clinical outcomes make him “the perfect person to accelerate OneOncology’s clinical network and fuel an expansion of clinical services. Dr. Daniel’s hands-on approach to medicine will be welcomed by all physicians on the OneOncology platform.”
Founder of OneOncology, Dr. Schwartzberg’s contributions are many. He established the company’s clinical network, served as the first president of the office of the chief medical officer, built and launched OneR, the company’s clinical research arm, and established the precision medicine initiative of OneOncology. Dr. Schwartzberg will continue at OneOncology as a Senior Advisor.
OneOncology was founded by community oncologists, for community oncologists, with a mission to improve the lives of all people with cancer. Our goal is to enable community oncology practices to remain independent, to improve patient access to care in their community, all at a lower cost than in a hospital setting. OneOncology supports our community oncology practice platform through group purchasing, operational optimization, practice growth and clinical innovation. Our 700 cancer care providers care for 280,000 patients at 181 care sites nationwide. To learn more, visit oneoncology.com or Linke